North America Multiplex Assay Market 2021-2028

According to this report, the multiplex assay market in North America is likely to reap a CAGR of 8.64% during the years 2021-2028. The United States and Canada collectively outline the market in the given region.

In the region, Canada has witnessed an increment in its healthcare expenses and ranks among the highest per capita spender among the OECD countries. This increase in healthcare expenditure surges the number of diagnostic procedures, thereby augmenting the demand for multiplex assays to carry out various diagnostics tests. Furthermore, as per Statistics Canada, the geriatric population base is anticipated to grow significantly by 2031. Thus, with the rise in the geriatric population, the prevalence of chronic diseases is likely to surge in the near future. This will enhance the need for diagnosis based on PCR devices for rapid and accurate diagnosis, thereby supporting the multiplex assay market’s growth across Canada.

Likewise, the US spends significantly on its healthcare expenditure. Moreover, the government’s spending on clinical laboratory services has surged in the past few years, enhancing the overall healthcare infrastructure. Additionally, the majority of the population is aware of the advantages of early diagnosis, increasing the chances of successful treatments. Thus, these factors are estimated to widen the scope and growth of the multiplex assay market across the United States over the next few years.

COMPETITIVE OUTLOOK

The companies thriving in the multiplex assay market are Abcam, Randox Laboratories Ltd, Meso Scale Diagnostics LLC, Merck Millipore, Seegene Inc, Becton Dickinson and Company, Agilent Technologies Inc, and Illumina Inc.

1. North America Multiplex Assay Market - Summary

2. Industry Outlook

2.1. Impact of COVID-19 on Multiplex Assay Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Key Buying Outlook
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Market Strategies
2.7.1. Contracts and Partnerships
2.7.2. Business Expansions, Announcements, & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. New Product Launches & Developments
2.8. Key Drivers
2.8.1. Adoption of Personalized Medicines
2.8.2. High Adoption of Multiplex Assays Over Traditional Methods
2.9. Key Restraints
2.9.1. Dearth of Skilled Professionals
2.9.2. Legal Trends Related to Environmental Safety
2.10. Key Opportunities
2.10.1. Funding for R&D Activities by Various Government Agencies and Companies

3. North America Multiplex Assay Market - by Product and Service

3.1. Reagents and Consumables
3.2. Instruments and Accessories
3.3. Software and Services

4. North America Multiplex Assay Market - by Type

4.1. Protein-Based Multiplex Assay
4.2. Nucleic Acid-Based Multiplex Assay
4.3. Other Multiplex Assays

5. North America Multiplex Assay Market - by Application

5.1. Research and Development
5.2. Clinical Diagnostics
5.3. Companion Diagnostics

6. North America Multiplex Assay Market - by Technology

6.1. Multiplex Protein Microarray
6.2. Multiplex Pcr
6.3. Other Technologies

7. North America Multiplex Assay Market - by Industry Verticals

7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
7.3. Clinical Laboratories
7.4. Hospitals

8. North America Multiplex Assay Market - Country Outlook

8.1. Country Analysis
8.1.1. United States
8.1.2. Canada

9. Competitive Landscape

9.1. Abcam
9.2. Agilent Technologies Inc
9.3. Becton Dickinson and Company
9.4. Bio Rad Laboratories Inc
9.5. Bio Techne Corporation
9.6. F Hoffmann La Roche
9.7. Illumina Inc
9.8. Luminex Corporation
9.9. Merck Millipore
9.10. Meso Scale Diagnostics LLC
9.11. Olink Proteomics Ab
9.12. Qiagen Nv
9.13. Randox Laboratories Ltd
9.14. Seegene Inc
9.15. Siemens Healthineers AG
9.16. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

10.1. Research Scope & Deliverables
10.1.1. Objectives of Study
10.1.2. Scope of Study
10.2. Sources of Data
10.2.1. Primary Data Sources
10.2.2. Secondary Data Sources
10.3. Research Methodology
10.3.1. Evaluation of Proposed Market
10.3.2. Identification of Data Sources
10.3.3. Assessment of Market Determinants
10.3.4. Data Collection
10.3.5. Data Validation & Analysis

List of Tables

Table 1: North America Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Contracts and Partnerships
Table 4: List of Business Expansions, Announcements, & Divestitures
Table 5: Acquisitions & Mergers
Table 6: List of New Product Launches & Developments
Table 7: North America Multiplex Assay Market, by Product and Service, 2021-2028 (In $ Million)
Table 8: North America Multiplex Assay Market, by Type, 2021-2028 (In $ Million)
Table 9: North America Multiplex Assay Market, by Application, 2021-2028 (In $ Million)
Table 10: North America Multiplex Assay Market, by Technology, 2021-2028 (In $ Million)
Table 11: North America Multiplex Assay Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 12: North America Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)

List of Figures

Figure 1: North America Multiplex Assay Market, 2021-2028 (In $ Million)
Figure 2: North America Multiplex Assay Market, by Product and Service, 2020 & 2028, (In%)
Figure 3: North America Multiplex Assay Market, by Reagents and Consumables, 2021-2028 (In $ Million)
Figure 4: North America Multiplex Assay Market, by Instruments and Accessories, 2021-2028 (In $ Million)
Figure 5: North America Multiplex Assay Market, by Software and Services, 2021-2028 (In $ Million)
Figure 6: North America Multiplex Assay Market, by Type, 2020 & 2028, (In%)
Figure 7: North America Multiplex Assay Market, by Protein-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 8: North America Multiplex Assay Market, by Nucleic Acid-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 9: North America Multiplex Assay Market, by Other Multiplex Assays, 2021-2028 (In $ Million)
Figure 10: North America Multiplex Assay Market, by Application, 2020 & 2028, (In%)
Figure 11: North America Multiplex Assay Market, by Research and Development, 2021-2028 (In $ Million)
Figure 12: North America Multiplex Assay Market, by Clinical Diagnostics, 2021-2028 (In $ Million)
Figure 13: North America Multiplex Assay Market, by Companion Diagnostics, 2021-2028 (In $ Million)
Figure 14: North America Multiplex Assay Market, by Technology, 2020 & 2028, (In%)
Figure 15: North America Multiplex Assay Market, by Multiplex Protein Microarray, 2021-2028 (In $ Million)
Figure 16: North America Multiplex Assay Market, by Multiplex Pcr, 2021-2028 (In $ Million)
Figure 17: Advantages of Immunohistochemistry (Ihc)
Figure 18: North America Multiplex Assay Market, by Other Technologies, 2021-2028 (In $ Million)
Figure 19: North America Multiplex Assay Market, by Industry Verticals, 2020 & 2028, (In%)
Figure 20: North America Multiplex Assay Market, by Pharmaceutical & Biotechnology Companies, 2021-2028 (In $ Million)
Figure 21: North America Multiplex Assay Market, by Research Institutes, 2021-2028 (In $ Million)
Figure 22: North America Multiplex Assay Market, by Clinical Laboratories, 2021-2028 (In $ Million)
Figure 23: North America Multiplex Assay Market, by Hospitals, 2021-2028 (In $ Million)
Figure 24: the United States Multiplex Assay Market, 2021-2028 (In $ Million)
Figure 25: Canada Multiplex Assay Market, 2021-2028 (In $ Million)